Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Bayer AG
Sponsor

Bayer AG

Germany -, 51368 Leverkusen, Germany

About the sponsor

Non-small cell lung cancer, solid tumors, and prostate cancer are prominent areas of interest, including disease settings defined by EGFR, HER2, NTRK fusion, KRAS G12C, and MTAP deletion. Research also extends to hepatocellular carcinoma and metastatic disease.

  • Advanced solid tumors
  • HER2-mutated cancers
  • Metastatic castration-resistant prostate cancer
  • NTRK-fusion malignancies

Interest includes both precision oncology and treatment strategies for advanced, refractory, and biomarker-defined cancers.

About Specializations

Bayer AG runs clinical trials in conditions such as Chronic kidney disease, Neoplasm malignant, Menopausal symptoms, Magnetic resonance imaging, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

41 clinical trials

Atrial fibrillation

Recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Bayer AG

Cardiac failure+1

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Cardiac failure+1

Recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Neoplasm malignant

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Bayer AG

Endometrial cancer+18

Recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bay 2927088
  • Sponsor:Bayer AG

Chronic kidney disease+1

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Magnetic resonance imaging

Not yet recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Gadoquatrane
  • Sponsor:Bayer AG

Chronic kidney disease+1

Not recruiting
InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Bayer AG

Ischaemic stroke+2

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Embolism

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Asundexian
  • Sponsor:Bayer AG

Testosterone deficiency syndrome+2

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Testosterone deficiency syndrome+2

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

ClinicalTrials.eu

Every clinical trial in Europe, in plain language.

Explore the full ecosystem of clinical research in Europe.

Search trials

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).